Home›Research›Compare›Cagrilintide vs CJC-1295
Peptide Comparison
Cagrilintide vs CJC-1295
Both are Fat Loss peptides.
Cagrilintide
AM833
Half-life: ~7 days
13 providers listed
CJC-1295
CJC-1295 DAC
Half-life: 6–8 days (DAC form)
429 providers listed
Quick Verdict
Cagrilintide
Risk
Half-life
~7 days
CJC-1295
Risk
Half-life
6–8 days (DAC form)
Side-by-Side Comparison
About Cagrilintide
Long-acting amylin analogue; acts on amylin/calcitonin receptors to prolong satiety; synergistic with semaglutide in CagriSema combination
A once-weekly long-acting amylin analogue in late-stage development. Showing impressive weight loss (~15%) in trials, especially when combined with semaglutide (CagriSema).
Research Areas
About CJC-1295
CJC-1295 binds to and activates pituitary GHRH receptors, stimulating pulsatile GH secretion. The DAC modification enables covalent binding to albumin, dramatically extending the active peptide half-life. This sustained GH pulse pattern is intended to mimic physiological GH release more closely than shorter-acting GHRH analogues.
CJC-1295 is a synthetic analogue of growth hormone-releasing hormone (GHRH). The DAC (Drug Affinity Complex) form binds to albumin in the bloodstream, extending its half-life to several days and enabling sustained elevation of GH and IGF-1 levels. It is commonly researched alongside GHRP peptides for body composition and recovery outcomes.
Research Areas
Find Providers
Where to source these peptides
Providers offering
Cagrilintide
13 listed
Browse directory →
Providers offering
CJC-1295
429 listed
Browse directory →
PeptideBase lists providers for educational research purposes only. Always consult a qualified healthcare professional before obtaining or using any peptide.
More fat loss Comparisons
Browse all peptides →Educational research tools — not medical advice.